Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Pd-catalyzed carbonylation method for quinazolinones using solid CO surrogate. Enhances safety and yield for API intermediates.
Advanced Cu-catalyzed synthesis of 1-substituted-1,2,3-triazoles from patent CN101792438B. Offers high purity, scalable routes for pharmaceutical intermediates and cost-effective manufacturing solutions.
Patent CN113045503B discloses a novel Pd-catalyzed carbonylation for 2-CF3 quinazolinones. High-yield, scalable route for API intermediates like Rutaecarpine.
Patent CN113105402B reveals a metal-free iodine-promoted route for 1,2,4-triazoles, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN109096139B discloses a novel metal-free method for preparing alpha-carbonyl amides using water as an oxygen source, offering significant cost and purity advantages for pharmaceutical intermediate manufacturing.
Novel metal-free synthesis for azaspiro tetraenone compounds. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Patent CN113105402B details a metal-free route to 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable production capabilities.
Novel palladium-catalyzed carbonylation method for synthesizing carbonyl-bridged biheterocycles without toxic CO gas, offering safer pharmaceutical intermediate manufacturing.
Novel palladium-catalyzed tandem reaction enables efficient one-step synthesis. Reduces complexity and enhances supply chain reliability for pharmaceutical intermediates.
Patent CN111848322B details a chiral phosphoric acid catalyzed resolution method yielding high-purity axially chiral oxindole-substituted styrenes for asymmetric catalysis applications.
Novel metal-free route for trifluoromethyl triazines. Reduces cost in API manufacturing with high purity and scalable conditions.
Novel chiral phosphoric acid catalyzed resolution method for axially chiral oxindole-substituted styrenes. High ee values up to 96%. Ideal for pharma intermediates.
Novel synthesis of axial chiral cyclopentenyl indole-naphthyl compounds via chiral phosphoric acid. High enantioselectivity and cytotoxic activity for pharmaceutical applications.
Novel palladium-catalyzed synthesis offers high efficiency and substrate compatibility for pharmaceutical intermediate manufacturing supply chains.
Patent CN117417339A details Rhodium-catalyzed synthesis offering high purity and scalable production for global pharmaceutical supply chains.
Patent CN113105402B reveals a metal-free route for 1,2,4-triazoles, offering cost reduction in API manufacturing and reliable pharmaceutical intermediate supply.
Patent CN112538059B enables high-purity oxazole-4-carboxylic ester manufacturing with atom economy. Reduces waste and cost for pharmaceutical intermediate supply chains globally.
Patent CN103554023B reveals mild ZnCl2 catalysis for high-yield acridine synthesis, offering cost-effective scalable solutions for pharmaceutical intermediates.
Patent CN112898192B details a novel Pd-catalyzed carbonylation route for N-acyl indoles, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN112694430B reveals a novel Pd-catalyzed bis-carbonylation route for 1,5-dihydro-2H-pyrrole-2-one intermediates, offering high efficiency and substrate compatibility for API manufacturing.